One of the few constants in the evolving government enforcement landscape is a focus on life sciences companies and their interactions and financial relationships with providers. In this final installment of our three-part Healthcare Litigation, Compliance & Enforcement webinar series, please join our white collar, life sciences and healthcare partners for a discussion of key enforcement risks facing life sciences companies.
During the session, we will offer practical tips on how to fine-tune compliance efforts in areas that are often scrutinized by the government and whistleblowers. Topics will include:
Partner | New York
Partner | Boston
Partner | Washington, DC
Partner | Chicago